Johnson & Johnson (NYSE: JNJ) has quietly emerged as a compelling turnaround story with its stock price rallying sharply in ...

The healthcare-products company is taking another shot at resolving mass cancer lawsuits in chapter 11 after two failed ...

A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an ...

and Janssen’s products were less addictive than other opioids,” the city’s lawyers wrote. Johnson & Johnson produced two opioid medications cited in the complaint: Duragesic, which was a ...

Johnson Controls (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, is showcasing its industry ...

A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an ...

As of September 19, 2024, Johnson & Johnson had a $400.0 billion market capitalization, putting it in the 100th percentile of companies in the Pharmaceuticals industry. Currently, Johnson & Johnson’s ...

Iowa RB Kaleb Johnson recorded a career-high 206 yards and three touchdowns to help lead Iowa to a 31-14 victory over ...

A Johnson & Johnson (J&J) subsidiary has filed for bankruptcy for a third time as the healthcare giant seeks to advance an ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on Johnson & Johnson (JNJ – Research Report). The ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...